CHER Cheelcare Inc.

0.9787USD1.400 CAD · TSXV0.00%Mkt Cap: 22.25M USDP/E: —

Cheelcare Inc. develops, manufactures, and distributes assistive mobility devices in the United States and Canada. It offers robotic complex rehab power wheelchairs, power add-ons for manual wheelchairs, and wheelchair a…

Key Statistics

Company
Market Cap22.25M USD
Enterprise Value22.08M USD
Revenue (TTM)1.62M USD
Gross Profit324.72K USD
Net Income (TTM)-3.40M USD
Revenue/Share0.08 USD
Last Price0.9787 USD
Fiscal Year EndApr 2026
MR QuarterJul 2026
Employees19
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA16308C1086
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-12.57
EV/Revenue13.62
P/S13.72
P/B12.07
EPS (TTM)-0.13 USD
EPS (Forward)—
52W Range
0.580250% of range1.384
52W High1.384 USD
52W Low0.5802 USD
Profitability
Gross Margin24.33%
Oper. Margin-108.61%
EBITDA Margin-108.34%
Profit Margin-254.56%
ROE-6411.68%
ROA-147.75%
ROIC-83.51%
ROCE-118.10%
Growth
Revenue Growth98.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.47M USD
CapEx (TTM)128.25K USD
FCF Margin-90.34%
FCF Yield-6.58%
Net Debt-162.80K USD
Net Debt/EBITDA0.09
Net Debt/FCF—
Balance Sheet
Debt/Equity30.39
Current Ratio3.63
Quick Ratio2.58
Book Value/Sh0.08 USD
Cash/Share0.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.22.73M
Float13.65M
Insiders39.23%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short205
Short (prev mo.)77
Technical
SMA 500.9564 (+2.3%)
SMA 2001.112 (-12.0%)
Beta0.04
S&P 52W Chg12.00%
Avg Vol (30d)9.31K
Avg Vol (10d)4.69K
Technical Indicators
RSI (14)55.7
MACD0.0170
MACD Signal-0.0066
MACD Hist.+0.0235
BB Upper1.024 USD
BB Middle0.9039 USD
BB Lower0.7838 USD
BB Width26.58%
ATR (14)0.0388 USD
Vol Ratio (20d)0.40x

About Cheelcare (CVE: CHER)

›

Cheelcare (CVE: CHER) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 19 employees.

The shares were at 1.400 CAD on 19 November 2026, up 66.7% over 52 weeks. Its 52-week range is 0.8300 CAD to 1.980 CAD: the price is 29.3% below the high and 68.7% above the low.

Its market capitalisation is 31.82M CAD.

Cheelcare reports an operating margin of -108.6% and revenue up 98.2% year over year.

It holds more cash than debt, a net cash position of 232.89K CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 30 December 2026.